Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 412

1.

Use of olanzapine for elderly patients with psychotic disorders: a review.

Madhusoodanan S, Sinha S, Brenner R, Gupta S, Bogunovic O.

Ann Clin Psychiatry. 2001 Dec;13(4):201-13. Review.

PMID:
11958362
[PubMed - indexed for MEDLINE]
2.

Efficacy and tolerability of olanzapine in elderly patients with psychotic disorders: a prospective study.

Madhusoodanan S, Brenner R, Suresh P, Concepcion NM, Florita CD, Menon G, Kaur A, Nunez G, Reddy H.

Ann Clin Psychiatry. 2000 Mar;12(1):11-8.

PMID:
10798821
[PubMed - indexed for MEDLINE]
3.

Objective and subjective efficacy as well as tolerability of olanzapine in the acute treatment of 120 patients with schizophrenia spectrum disorders.

Lambert M, Holzbach R, Moritz S, Postel N, Krausz M, Naber D.

Int Clin Psychopharmacol. 2003 Sep;18(5):251-60.

PMID:
12920385
[PubMed - indexed for MEDLINE]
4.

Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol.

Lieberman JA, Tollefson G, Tohen M, Green AI, Gur RE, Kahn R, McEvoy J, Perkins D, Sharma T, Zipursky R, Wei H, Hamer RM; HGDH Study Group.

Am J Psychiatry. 2003 Aug;160(8):1396-404.

PMID:
12900300
[PubMed - indexed for MEDLINE]
5.

Review of recent clinical studies with olanzapine.

Tollefson GD, Kuntz AJ.

Br J Psychiatry Suppl. 1999;(37):30-5. Review.

PMID:
10211139
[PubMed - indexed for MEDLINE]
6.

The efficacy and safety of olanzapine for the treatment of geriatric psychosis.

Hwang JP, Yang CH, Lee TW, Tsai SJ.

J Clin Psychopharmacol. 2003 Apr;23(2):113-8.

PMID:
12640211
[PubMed - indexed for MEDLINE]
7.

Olanzapine: an atypical antipsychotic for schizophrenia.

Lund BC, Perry PJ.

Expert Opin Pharmacother. 2000 Jan;1(2):305-23. Review.

PMID:
11249551
[PubMed - indexed for MEDLINE]
8.

Switching treatment-resistant patients with schizophrenia or schizoaffective disorder to olanzapine: a one-year open-label study with five-year follow-up.

Karagianis JL, LeDrew KK, Walker DJ.

Curr Med Res Opin. 2003;19(6):473-80.

PMID:
14594518
[PubMed - indexed for MEDLINE]
9.

Adverse events related to olanzapine.

Conley RR, Meltzer HY.

J Clin Psychiatry. 2000;61 Suppl 8:26-9; discussion 30. Review.

PMID:
10811240
[PubMed - indexed for MEDLINE]
10.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
[PubMed - indexed for MEDLINE]
11.

Olanzapine: a new antipsychotic agent with efficacy in the management of schizophrenia.

Kando JC, Shepski JC, Satterlee W, Patel JK, Reams SG, Green AI.

Ann Pharmacother. 1997 Nov;31(11):1325-34. Review.

PMID:
9391688
[PubMed - indexed for MEDLINE]
12.
13.

Olanzapine: a novel atypical neuroleptic agent.

Reus VI.

Lancet. 1997 May 3;349(9061):1264-5. No abstract available. Erratum in: Lancet 1997 Aug 2;350(9074):372.

PMID:
9142055
[PubMed - indexed for MEDLINE]
14.

The impact upon extra-pyramidal side effects, clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics (risperidone or olanzapine) in elderly patients with schizophrenia.

Ritchie CW, Chiu E, Harrigan S, Hall K, Hassett A, Macfarlane S, Mastwyk M, O'Connor DW, Opie J, Ames D.

Int J Geriatr Psychiatry. 2003 May;18(5):432-40.

PMID:
12766921
[PubMed - indexed for MEDLINE]
15.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

PMID:
14994733
[PubMed - indexed for MEDLINE]
16.

Olanzapine and the new generation of antipsychotic agents: patterns of use.

Glazer WM.

J Clin Psychiatry. 1997;58 Suppl 10:18-21. Review.

PMID:
9265912
[PubMed - indexed for MEDLINE]
17.

Conventional vs. newer antipsychotics in elderly patients.

Jeste DV, Rockwell E, Harris MJ, Lohr JB, Lacro J.

Am J Geriatr Psychiatry. 1999 Winter;7(1):70-6. Review.

PMID:
9919323
[PubMed - indexed for MEDLINE]
18.

Comparison of risperidone and olanzapine in the control of negative symptoms of chronic schizophrenia and related psychotic disorders in patients aged 50 to 65 years.

Feldman PD, Kaiser CJ, Kennedy JS, Sutton VK, Tran PV, Tollefson GD, Zhang F, Breier A.

J Clin Psychiatry. 2003 Sep;64(9):998-1004.

PMID:
14628974
[PubMed - indexed for MEDLINE]
19.

Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study.

Lindenmayer JP, Czobor P, Volavka J, Lieberman JA, Citrome L, Sheitman B, Chakos M, McEvoy JP.

J Clin Psychiatry. 2002 Oct;63(10):931-5.

PMID:
12416603
[PubMed - indexed for MEDLINE]
20.

Risperidone and olanzapine: optimal dosing for efficacy and tolerability in patients with schizophrenia.

Kasper S.

Int Clin Psychopharmacol. 1998 Nov;13(6):253-62. Review.

PMID:
9861575
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk